ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer

Li, He; Gu, Jie; Tian, Yuqiu; Li, Shuyu; Zhang, Hao; Dai, Ziyu; Wang, Zeyu; Zhang, Nan*; Peng, Renjun*华中科技大学; 哈尔滨医科大学
Frontiers in Immunology2022-10-17DOI: 10.3389/fimmu.2022.982628
1被引6阅读
引用收藏
分享

摘要

BackgroundProstate cancer (PCa), a prevalent malignant cancer in males worldwide, screening for patients might benefit more from immuno-/chemo-therapy remained inadequate and challenging due to the heterogeneity of PCa patients. Thus, the study aimed to explore the metabolic (Meta) characteristics and develop a metabolism-based signature to predict the prognosis and immuno-/chemo-therapy response for PCa patients. MethodsDifferentially expressed genes were screened among 2577 metabolism-associated genes. Univariate Cox analysis and random forest algorithms was used for features screening. Multivariate Cox regression analysis was conducted to construct a prognostic Meta-model based on all combinations of metabolism-related features. Then the correlation between MetaScore and tumor was deeply explored from prognostic, genomic variant, functional and immunological perspectives, and chemo-/immuno-therapy response. Multiple algorithms were applied to estimate the immunotherapeutic responses of two MeteScore groups. Further in vitro functional experiments were performed using PCa cells to validate the association between the expression of hub gene SLC17A4 which is one of the model component genes and tumor progression. GDSC database was employed to determine the sensitivity of chemotherapy drugs. ResultsTwo metabolism-related clusters presented different features in overall survival (OS). A metabolic model was developed weighted by the estimated regression coefficients in the multivariate Cox regression analysis (0.5154*GAS2 + 0.395*SLC17A4 - 0.1211*NTM + 0.2939*GC). This Meta-scoring system highlights the relationship between the metabolic profiles and genomic alterations, gene pathways, functional annotation, and tumor microenvironment including stromal, immune cells, and immune checkpoint in PCa. Low MetaScore is correlated with increased mutation burden and microsatellite instability, indicating a superior response to immunotherapy. Several medications that might improve patients` prognosis in the MetaScore group were identified. Additionally, our cellular experiments suggested knock-down of SLC17A4 contributes to inhibiting invasion, colony formation, and proliferation in PCa cells in vitro. ConclusionsOur study supports the metabolism-based four-gene signature as a novel and robust model for predicting prognosis, and chemo-/immuno-therapy response in PCa patients. The potential mechanisms for metabolism-associated genes in PCa oncogenesis and progression were further determined.

学科与关键词

关键词
prostate cancermetabolismprognostic modelimmuno-chemotherapy responseimmune infiltration
相关
加载中…
  • Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
    Zhang, Guian; Luo, Yong; Dong, Weimin; Zhong, Weide*Computational and Mathematical Methods in Medicine, 2022, 2022: 8233840.被引 4
  • Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
    Luo, Yong; Liu, Xiaopeng; Lin, Jingbo*; Zhong, Weide*; Chen, Qingbiao*Mathematical Biosciences and Engineering, 2022, 19(11): 11345-11366.
  • Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
    Zou, Zhihao; Liu, Ren; Liang, Yingke; Zhou, Rui; Dai, Qishan; Han, Zhaodong; Jiang, Minyao; Zhuo, Yangjia; Zhang, Yixun; Feng, Yuanfa; Zhu, Xuejin; Cai, Shanghua; Lin, Jundong; Tang, Zhenfeng; Zhong, Weide*; Liang, Yuxiang*Frontiers in Genetics, 2021, 12: 703210.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-10-17
卷期
第 13 卷
页码
982628
DOI
10.3389/fimmu.2022.982628
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Science and Technology Innovation Program of Hunan Province; Youth Natural Science Foundation of Hunan Province; [81901268]; [2020RC2065]; [2021JJ40321]

作者

  • L

    Li, He (第一作者)

    hunan canc hosp

  • G

    Gu, Jie

查看全部 9 位作者收起作者
  • T

    Tian, Yuqiu

  • L

    Li, Shuyu

    huazhong univ sci & technol

  • Z

    Zhang, Hao

  • D

    Dai, Ziyu

  • W

    Wang, Zeyu

  • Z

    Zhang, Nan (通讯)

    harbin med univ

  • P

    Peng, Renjun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417